Management of T2DM Flashcards

1
Q

what is the main treatment outline

A
  1. metformin
  2. metformin plus non injectable
  3. metformin plus plus GLP1 or insulin
  4. 4
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

action of metformin

A

suppress hepatic gluconeogensis, reducing glucose output from liver and increase glucose uptake

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

name of a sulphonylurea

A

gliclazide

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

benefits of metformin

A

Moderate efficacy, weight reduction, low hypo risk, CV benefit, extensive experience

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

benefits of sulphonylurea

A

High efficacy, extensive experience experience

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

side effects of metformin

A

GI side effects, No if eGFR<30, small risk of lactic acidosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

sulphonylurea action

A

•Close potassium channels on beta cells, stimulating release of stored insulin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

side effects of sulphonylurea

A

No CV benefit, weight gain, high hypo risk, caution in CKD
Less effective over time because like squeezing insulin from a sponge, not effective in type 1 as nothing there in first place

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

name a DPP4 inhibitor

A

linagliptin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

DPP4 inhibitor benefits

A

Low/Moderate efficacy, low hypo risk, few adverse events

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

DPP4 inhibits action

A

•Inhibit DPP-4 and enhance effects of endogenous incretins (eg. GLP-1)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

SGLT 2 inhibitor action

A

•Inhibit SGLT2 in the proximal convoluted tubule of the kidney

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

benefits of SGLT 2

A

Moderate efficacy, CV benefit (BP + HF), renal benefit (CANA), Weight loss, low hypo risk, reduced CV events

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

side effects of SGLT 2

A

Risk of GU infections, Small risk of hypovolaemia/DKA, do not start if eGFR<60

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

how do thiazolidinediones work

A

PPAR gamma-receptor agonists
•Increase sensitivity of fat, muscles, and liver to endogenous and exogenous insulin
Rarely used

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

name a thiazolidinediones

A

pioglitazone

17
Q

benefit of thiazolidinediones

A

Moderate efficacy, probably CV protection, low hypo risk, past experience

18
Q

side effects of thiazolidinediones

A

Weight gain, fluid retention, fractures

19
Q

GLP 1 receipt antagonist how it works

A

•Increase glucose mediated insulin secretion, suppress glucagon secretion

20
Q

benefits of GLP 1

A

High efficacy, CV benefit, low hypo risk, weight loss injected,

21
Q

side effects of GLP 1

A

GI side effects, uncertain safety re. pancreas

22
Q

name of GLP1

A

exanatide

23
Q

inlsuin how it works

A
  • Increase glucose uptake and utilisation in skeletal muscle
  • Reduce hepatic glucose output, increase glycogenesis
  • Decrease lipolysis
  • Decrease gluconeogenesis
24
Q

benefits of insulin

A

High efficacy, extensive experience

25
Q

aide effects of insulin

A

Injected, No CV benefit, weight gain,

highest hypoglycaemia risk

26
Q

DPP4 inhibitor side effects

A

Weight neutral, no CV benefit, reduce dose in CKD